Luminol As In Situ Light Source in Meso-Tetraphenylporphyrin-Mediated Photodynamic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|9|1195-1202

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.9, 2013-03, pp. : 1195-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy

By Konan Y.N.   Cerny R.   Favet J.   Berton M.   Gurny R.   Allemann E.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Targeted photodynamic therapy via receptor mediated delivery systems

By Sharman W.M.   van Lier J.E.   Allen C.M.  

Advanced Drug Delivery Reviews, Vol. 56, Iss. 1, 2004-01 ,pp. : 53-76

Elsevier

Access to resources Recommend Favorite

Temoporfin-mediated photodynamic therapy shows efficacy in the treatment of BCC

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Commentary: Shining the Light on Photodynamic Therapy in the Treatment of Extramammary Paget's Disease

By CHERPELIS BASIL S.  

Dermatologic Surgery, Vol. 36, Iss. 11, 2010-11 ,pp. : 1725-1725

Elsevier

Access to resources Recommend Favorite

Aminolevulinic Acid Derivatives and Liposome Delivery as Strategies for Improving 5-Aminolevulinic Acid- Mediated Photodynamic Therapy

By  

Current Medicinal Chemistry, Vol. 13, Iss. 10, 2006-04 ,pp. : 1157-1168

Bentham Science Publishers

Access to resources Recommend Favorite